Request TOC and Sample - Anxiety disorders and depression treatment Market by DRUG CLASS (SSRIs (Selective Serotonin Reuptake Inhibitors), SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors), TeCAs (Tetracyclic Antidepressants), TCAs (Tricyclic Antidepressants), MAOIs (Monoamine Oxidase inhibitors), Atypical Antipsychotics, Benzodiazepines, Anticonvulsants, Beta-Blockers, Others) and by PIPELINE ANALYSIS (Brintellix (Vortioxetine - Lu AA21004), ALKS-5461, Brexpiprazole (OPC-34712)): Global Opportunity Analysis and Industry Forecast, 2023-2032

Anxiety disorders and depression treatment Market, by DRUG CLASS (SSRIs (Selective Serotonin Reuptake Inhibitors), SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors), TeCAs (Tetracyclic Antidepressants), TCAs (Tricyclic Antidepressants), MAOIs (Monoamine Oxidase inhibitors), Atypical Antipsychotics, Benzodiazepines, Anticonvulsants, Beta-Blockers, Others) and, by PIPELINE ANALYSIS (Brintellix (Vortioxetine - Lu AA21004), ALKS-5461, Brexpiprazole (OPC-34712)): Global Opportunity Analysis and Industry Forecast, 2023-2032